Receps Limited

RECEPS Ltd. adopts a three-pronged approach to create a strong foundation of customer base and product base - the first one being the development of manufacturing technology for Active Pharmaceutical Ingredients (API) and intermediates/KSMs for Pharmaceutical companies. Second, R&D development and manufacturing services to pharmaceutical companies through CDMO, CRO, CMO, FTE, and FFS models to support their research, development, and manufacturing requirements. The third one is extensive Analytical Services, IP Services and Regulatory Services to pharmaceutical companies. PHARMACEUTICAL SERVICES • Advanced analytical services with 21CFR Part 11 compliant labs. • Impurity Profiling and Impurity Synthesis • Stability Studies • Analytical Method Development • Analytical Method Validation / Verification • Structural Characterization of APIs, Impurities and Intermediates • Batch Analysis of Drug Substances. • Carry Over/Residue Studies for Reagents, Intermediates, Solvents, and RMs. • Forced Degradation of APIs • Develop manufacturing processes for pharmaceutical products and intermediates. • Custom synthesis, CDMO, CRO, CMO, FTE, and FFS Services; Complex Chemistry. • Scientific Risk Assessment & Analysis of Genotoxic Impurities, Nitrosamines and Elemental Impurities • Regulatory Services - Audits and Dossier filing. • IP Landscape, IP Analysis of Processes, Patent Filing and Patent Prosecutions • Invalidation Study and grounds to handle Para-IV litigations